Daptomycin for the treatment of gram-positive infections after cardiac surgery

被引：0
|
作者：
Luchting, B. [1 ]
Weis, F. [1 ]
Heyn, J. [1 ]
Beiras-Fernandez, A. [2 ,3 ]
机构：
[1] Klinikum Univ Munchen, Klin Anaesthesiol, Munich, Germany
[2] Klinikum Univ Munchen, Herzchirurg Klin & Poliklin, Munich, Germany
[3] Klinikum Johann Wolfgang Goethe Univ, D-60590 Frankfurt, Germany
来源：
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2013年 / 108卷 / 01期
关键词：
Gram-positive Infections; Daptomycin; Cardiac surgery; Resistences; Efficacy; RESISTANT STAPHYLOCOCCUS-AUREUS; MAJOR HEART-SURGERY; POSTOPERATIVE MEDIASTINITIS; CLINICAL-EVIDENCE; JOINT INFECTIONS; VANCOMYCIN; THERAPY; ENDOCARDITIS; BACTEREMIA; PATIENT;
D O I：
10.1007/s00063-012-0163-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background and method. Surgical infection remains a main cause of death after heart surgery, despite advances in pharmacological therapy. Daptomycin is a cyclic lipopeptide antibiotic, useful in gram-positive organisms resistant to standard treatment, including vancomycin. The aim of this study was to describe the use of daptomycin regarding efficacy, efficiency and safety in patients with gram-positive infections after heart surgery using a retrospective analysis on 49 adult patients. Conclusion. Daptomycin shows excellent in vitro and in vivo activity against gram-positive organisms, such as Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, especially MRSA. Daptomycin is also effective against increasing vancomycin-resistant or vancomycin-intermediate S. aureus.
引用
收藏
页码：59 / 62
页数：4
相关论文
共 50 条
  • [31] Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient
    Garnacho-Montero, Jose
    Amaya-Villar, Rosario
    Luisa Gomez-Grande, Ma
    Jerez Gomez-Coronado, Vicente
    Lorente-Ramos, Leonardo
    Loza Vazquez, Ana
    Martinez Pellus, Antonio
    Pozo Laderas, Juan Carlos
    Sierra Camerino, Rafael
    Pomares Mora, Jose
    de la Torre Prados, Ma Victoria
    Ortiz Leyba, Carlos
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2011, 24 (01) : 13 - 24
  • [32] Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry
    Gonzalez-Ruiz, Armando
    Gargalianos-Kakolyris, Panayiotis
    Timerman, Artur
    Sarma, Jayanta
    Gonzalez Ramallo, Victor Jose
    Bouylout, Kamel
    Trostmann, Uwe
    Pathan, Rashidkhan
    Hamed, Kamal
    ADVANCES IN THERAPY, 2015, 32 (06) : 496 - 509
  • [33] Daptomycin use in neutropenic patients with documented gram-positive infections
    Kenneth V. I. Rolston
    Dina Besece
    Kenneth C. Lamp
    Min Yoon
    Scott A. McConnell
    Pamela White
    Supportive Care in Cancer, 2014, 22 : 7 - 14
  • [34] Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
    Cataldo, Maria Adriana
    Tacconelli, Evelina
    Grilli, Elisabetta
    Pea, Federico
    Petrosillo, Nicola
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 17 - 24
  • [35] Daptomycin therapy for invasive Gram-positive bacterial infections in children
    Ardura, Monica I.
    Mejias, Asuncion
    Katz, Kathy S.
    Revell, Paula
    McCracken, George H., Jr.
    Sanchez, Pablo J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (12) : 1128 - 1132
  • [36] Newer developments in the treatment of Gram-positive infections
    Koomanachai, Pornpan
    Crandon, Jared L.
    Nicolau, David P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (17) : 2829 - 2843
  • [37] Daptomycin: The role of high-dose and combination therapy for Gram-positive infections
    Gould, Ian M.
    Miro, Jose M.
    Rybak, Michael J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (03) : 202 - 210
  • [38] The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections
    Jugun, Kheeldass
    Vaudaux, Pierre
    Garbino, Jorge
    Pagani, Leonardo
    Hoffmeyer, Pierre
    Lew, Daniel
    Uckay, Ilker
    INTERNATIONAL ORTHOPAEDICS, 2013, 37 (07) : 1375 - 1380
  • [39] High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
    Kullar, Ravina
    Davis, Susan L.
    Levine, Donald P.
    Zhao, Jing J.
    Crank, Christopher W.
    Segreti, John
    Sakoulas, George
    Cosgrove, Sara E.
    Rybak, Michael J.
    PHARMACOTHERAPY, 2011, 31 (06): : 527 - 536
  • [40] Empirical therapy for serious Gram-positive infections: making the right choice
    Segreti, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 5 - 10
12345